About Saluda Medical
Saluda Medical is a company based in Bloomington (United States) founded in 2010.. Saluda Medical has raised $530 million across 9 funding rounds from investors including Fidelity Investments, Medtronic and Boston Scientific. Saluda Medical offers products and services including Evoke System and SmartLoop Technology. Saluda Medical operates in a competitive market with competitors including Myoscience, Nalu Medical, Neuros Medical, Biowave and Alpha-Stim, among others.
- Headquarter Bloomington, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Saluda Medical Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$530 M (USD)
in 9 rounds
-
Latest Funding Round
$30 M (USD), Series B
Oct 30, 2025
-
Investors
Fidelity Investments
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Saluda Medical
Saluda Medical is a publicly listed company on the ASX with ticker symbol SLD in Australia. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Saluda Medical
Saluda Medical offers a comprehensive portfolio of products and services, including Evoke System and SmartLoop Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for closed-loop spinal cord stimulation to treat chronic pain.
Technology that adjusts neural stimulation based on patient responses.
Unlock access to complete
Software Development Team
54 people
Senior Team
20 people
Sales and Marketing
11 people
Leadership Team
9 people
Operations Team
8 people
Clinical Team
5 people
Human Resources and Administration
5 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Saluda Medical
Saluda Medical has successfully raised a total of $530M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $30.0M
-
First Round
First Round
(20 Feb 2012)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series B - Saluda Medical | Valuation |
investors |
|
| Jan, 2025 | Amount | Series F - Saluda Medical | Valuation | Redmile Group | |
| Apr, 2023 | Amount | Series F - Saluda Medical | Valuation | Wellington |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Saluda Medical
Saluda Medical has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Medtronic and Boston Scientific. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are pursued.
|
Founded Year | Domain | Location | |
|
BioScience Managers is engaged in healthcare investment and innovation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Saluda Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Saluda Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Saluda Medical Comparisons
Competitors of Saluda Medical
Saluda Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Myoscience, Nalu Medical, Neuros Medical, Biowave and Alpha-Stim, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Technology-driven dermatological products are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| domain | founded_year | HQ Location |
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
|
|
| domain | founded_year | HQ Location |
Neuromodulation devices are developed for pain therapy management.
|
|
| domain | founded_year | HQ Location |
Non-drug electrotherapy devices for pain and anxiety are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Saluda Medical
Frequently Asked Questions about Saluda Medical
When was Saluda Medical founded?
Saluda Medical was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is Saluda Medical located?
Saluda Medical is headquartered in Bloomington, United States. It is registered at Bloomington, Indiana, United States.
Who is the current CEO of Saluda Medical?
Jim Schuermann is the current CEO of Saluda Medical.
Is Saluda Medical a funded company?
Saluda Medical is a funded company, having raised a total of $530M across 9 funding rounds to date. The company's 1st funding round was a Series F of $150M, raised on Feb 20, 2012.
What does Saluda Medical do?
Founded in 2010 and headquartered in Bloomington, United States, Saluda Medical operates in the neuromodulation sector. A system is provided that measures and records neural activation characteristics for treating chronic neurological conditions, particularly pain. Stimulation levels are quantified against clinician-defined targets, with continuous comparisons and automatic adjustments to maintain consistent activation. Evoked Compound Action Potentials are utilized to enhance therapy precision.
Who are the top competitors of Saluda Medical?
Saluda Medical's top competitors include Nalu Medical, Myoscience and Neuros Medical.
What products or services does Saluda Medical offer?
Saluda Medical offers Evoke System and SmartLoop Technology.
Is Saluda Medical publicly traded?
Yes, Saluda Medical is publicly traded on ASX under the ticker symbol SLD.
Who are Saluda Medical's investors?
Saluda Medical has 11 investors. Key investors include Fidelity Investments, Medtronic, Boston Scientific, TPG, and T. Rowe Price.
What is Saluda Medical's ticker symbol?
The ticker symbol of Saluda Medical is SLD on ASX.